A detailed history of Paragon Capital Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Paragon Capital Management LTD holds 6,281 shares of ABT stock, worth $719,111. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,281
Previous 6,554 4.17%
Holding current value
$719,111
Previous $681,000 5.14%
% of portfolio
0.15%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$100.07 - $118.13 $27,319 - $32,249
-273 Reduced 4.17%
6,281 $716,000
Q2 2024

Jul 12, 2024

BUY
$100.73 - $112.44 $302 - $337
3 Added 0.05%
6,554 $681,000
Q1 2024

Apr 11, 2024

BUY
$109.52 - $120.96 $219 - $241
2 Added 0.03%
6,551 $744,000
Q4 2023

Jan 12, 2024

BUY
$90.19 - $110.4 $180 - $220
2 Added 0.03%
6,549 $720,000
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $18,914 - $22,694
-198 Reduced 2.94%
6,547 $634,000
Q2 2023

Jul 11, 2023

SELL
$100.78 - $112.29 $66,212 - $73,774
-657 Reduced 8.88%
6,745 $735,000
Q1 2023

Apr 13, 2023

SELL
$96.86 - $114.01 $43,393 - $51,076
-448 Reduced 5.71%
7,402 $749,000
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $190 - $223
2 Added 0.03%
7,850 $0
Q3 2022

Oct 14, 2022

SELL
$96.76 - $112.03 $43,445 - $50,301
-449 Reduced 5.41%
7,848 $759,000
Q2 2022

Jul 18, 2022

SELL
$102.07 - $123.37 $55,934 - $67,606
-548 Reduced 6.2%
8,297 $901,000
Q1 2022

Apr 19, 2022

SELL
$114.02 - $139.04 $16,874 - $20,577
-148 Reduced 1.65%
8,845 $1.05 Million
Q4 2021

Jan 27, 2022

BUY
$115.53 - $141.46 $115 - $141
1 Added 0.01%
8,993 $1.27 Million
Q3 2021

Oct 19, 2021

SELL
$116.66 - $129.06 $22,515 - $24,908
-193 Reduced 2.1%
8,992 $1.06 Million
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $211 - $249
2 Added 0.02%
9,185 $1.07 Million
Q1 2021

Apr 21, 2021

BUY
$108.84 - $128.23 $108 - $128
1 Added 0.01%
9,183 $1.1 Million
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $735 - $800
-7 Reduced 0.08%
9,182 $1.01 Million
Q3 2020

Oct 22, 2020

BUY
$91.64 - $111.29 $91 - $111
1 Added 0.01%
9,189 $1 Million
Q2 2020

Jul 27, 2020

BUY
$76.57 - $98.0 $703,525 - $900,424
9,188 New
9,188 $840,000
Q1 2020

Apr 29, 2020

SELL
$62.82 - $91.86 $576,938 - $843,642
-9,184 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$78.51 - $87.4 $78 - $87
1 Added 0.01%
9,184 $798,000
Q3 2019

Oct 18, 2019

BUY
$81.84 - $88.74 $163 - $177
2 Added 0.02%
9,183 $768,000
Q2 2019

Jul 23, 2019

BUY
$72.88 - $85.0 $145 - $170
2 Added 0.02%
9,181 $772,000
Q1 2019

May 01, 2019

BUY
$66.22 - $80.06 $66 - $80
1 Added 0.01%
9,179 $734,000
Q4 2018

Jan 29, 2019

SELL
$65.56 - $74.27 $2,884 - $3,267
-44 Reduced 0.48%
9,178 $664,000
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $9,851 - $11,884
162 Added 1.79%
9,222 $677,000
Q1 2018

Apr 24, 2018

SELL
$56.27 - $63.62 $63,697 - $72,017
-1,132 Reduced 11.11%
9,060 $543,000
Q3 2017

Oct 26, 2017

BUY
$48.06 - $53.64 $489,827 - $546,698
10,192
10,192 $544,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Paragon Capital Management LTD Portfolio

Follow Paragon Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.